| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10428194.2014.909039 |
| P698 | PubMed publication ID | 24684227 |
| P50 | author | Richard W. Tsang | Q55091078 |
| P2093 | author name string | David Hodgson | |
| Melania Pintilie | |||
| Michael Crump | |||
| Mary Gospodarowicz | |||
| John Kuruvilla | |||
| Luluel Khan | |||
| Alex Sun | |||
| P2860 | cites work | Host ethnicity influences non-Hodgkin's lymphoma subtype frequency and Epstein-Barr virus association rate: the experience of a multi-ethnic patient population in Malaysia | Q30680953 |
| Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience | Q33395423 | ||
| Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study. | Q35010999 | ||
| International analysis of the frequency and outcomes of NK/T-cell lymphomas | Q38114559 | ||
| Incidence and spectrum of non-Hodgkin lymphoma in Chinese migrants to British Columbia | Q38474854 | ||
| Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints. | Q40498958 | ||
| Successful treatment with Erwinia L-asparaginase for recurrent natural killer/T cell lymphoma | Q40557017 | ||
| L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation | Q40590196 | ||
| Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract | Q43789503 | ||
| NK/T-cell lymphomas 'nasal type': an Italian multicentric retrospective survey. | Q44862538 | ||
| Prognosis and primary therapy in peripheral T-cell lymphomas | Q46202589 | ||
| Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study | Q46462344 | ||
| Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia | Q46738245 | ||
| Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. | Q51403316 | ||
| Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. | Q54156188 | ||
| Life-style and environmental factors in the development of nasal NK/T-cell lymphoma: a case-control study in East Asia | Q57212503 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 80-84 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Leukemia & Lymphoma | Q6534493 |
| P1476 | title | A single institution experience of extranodal natural killer/T cell lymphoma of nasal type | |
| P478 | volume | 56 |
| Q46889433 | Comparison of chemoradiotherapy with radiotherapy alone for early-stage extranodal natural killer/T-cell lymphoma, nasal type in elderly patients. |
| Q30244110 | Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases |
| Q39377852 | L-Asparaginase for newly diagnosed extra-nodal NK/T-cell lymphoma: systematic review and meta-analysis |
| Q55094448 | Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma. |
| Q37458786 | Predictors of survival of natural killer/T-cell lymphoma, nasal type, in a non-Asian population: a single cancer centre experience |
Search more.